Search for Open Studies


To inquire about current studies please contact Nicklaus Children's Research Institute  at:

Research Study: How your child's genetic makeup can impact the way he or she responds to certain medications

Enzymes are particularly important in the processing of medicines and drugs. They determine how our bodies are going to handle the medicines we take, and if those medicines are going to help us feel better or not. This research study includes testing the status of the CYP2D6 gene in children.

List of Clinical Research Studies Nicklaus Children's Hospital is participating in:

Recruiting:
Condition: Benign Centrally-Located Intracranial Tumors
Intervention: Device: ExAblate 4000 System
Age: 8 Years to 22 Years   (Child, Adult)
Study Start: January 12, 2017
Study Completion: December 31, 2023
Recruiting:

COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction

Conditions: Pulmonary Valve Insufficiency;   Pulmonary Valve Stenosis;   Heart Defects, Congenital;   Congenital Abnormalities;   Cardiovascular Diseases;   Heart Diseases
Intervention: Device: SAPIEN XT THV
Age: 19 Years and older   (Adult, Senior)
Study Start: May 2017
Study Completion: January 2024
Recruiting:
Conditions: Germ Cell Tumor;   Teratoma;   Choriocarcinoma;   Germinoma;   Mixed Germ Cell Tumor;   Yolk Sac Tumor;   Childhood Teratoma;   Malignant Germ Cell Neoplasm;   Extragonadal Seminoma;   Non-seminomatous Germ Cell Tumor;   Seminoma
Interventions: Drug: paclitaxel;   Drug: ifosfamide;   Drug: cisplatin;   Drug: pegylated G-CSF;   Drug: G-CSF;   Drug: carboplatin;   Drug: etoposide phosphate;   Procedure: stem cell reinfusion
Age: 14 Years and older   (Child, Adult, Senior)
Study Start: March 2015
Study Completion:  
Condition: Persistent Pulmonary Hypertension of the Newborn
Interventions: Drug: IV Remodulin;   Drug: Placebo
Age: up to 14 Days   (Child)
Study Start: May 2015
Study Completion: